Detection of the Highest-Grade Lesion in Multifocal Discordant Prostate Cancer by Multiparametric Magnetic Resonance Imaging.

Dominant tumor Index tumor PI-RADS Radical prostatectomy mpMRI

Journal

Clinical genitourinary cancer
ISSN: 1938-0682
Titre abrégé: Clin Genitourin Cancer
Pays: United States
ID NLM: 101260955

Informations de publication

Date de publication:
21 Mar 2024
Historique:
received: 12 02 2024
accepted: 18 03 2024
medline: 13 4 2024
pubmed: 13 4 2024
entrez: 12 4 2024
Statut: aheadofprint

Résumé

Prostate cancer generally occurs multifocally. The lesions of the largest size and highest-grade are often concordant, and defined as an index tumor. However, these factors sometimes do not coincide within one lesion. In such discordant cases, not the largest size lesion but the highest-grade lesion is known to determine the prognosis. We focused on the multiparametric magnetic resonance imaging (mpMRI) detectability of the highest-grade tumors in discordant cases. We investigated the detectability of the highest-grade tumor using preoperative mpMRI in 50 discordant patients who underwent radical prostatectomy. The radiologist was informed of the tumor location on the pathological tumor map, and mpMRI interpretation for each tumor was performed. Prostate Imaging-Reporting and Data System (PI-RADS) scores of 1, 2, 3, 4, and 5 on preoperative mpMRI were assigned to 13, 1, 9, 16, and 11 of the largest tumors, respectively. On the other hand, scores of 1, 2, 3, 4, and 5 were assigned to 23, 0, 7, 19, and 1 of the highest-grade tumors, respectively. The difference between them was statistically significant (p=0.007). We also found that the largest anterior tumor frequently hid the ipsilateral posterior highest-grade tumor; the detection rate of the highest-grade tumor in this pattern was 42.1% (8 of 19 cases) CONCLUSION: We found that mpMRI detectability of the highest-grade tumor in discordant cases was inferior to that of the largest tumor with low malignant potential. Our results suggest that the risk of high-grade tumors which determine patient prognosis being overlooked.

Identifiants

pubmed: 38608334
pii: S1558-7673(24)00055-7
doi: 10.1016/j.clgc.2024.102084
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102084

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Auteurs

Kazuhiro Matsumoto (K)

Department of Urology, Keio University School of Medicine, Tokyo, Japan. Electronic address: kazz_matsumoto@yahoo.co.jp.

Hirotaka Akita (H)

Department of Diagnostic Radiology, Keio University School of Medicine, Tokyo, Japan.

Akinori Hashiguchi (A)

Department of Pathology, Keio University School of Medicine, Tokyo, Japan.

Toshikazu Takeda (T)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Takeo Kosaka (T)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Keishiro Fukumoto (K)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Yota Yasumizu (Y)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Nobuyuki Tanaka (N)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Shinya Morita (S)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Ryuichi Mizuno (R)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Hiroshi Asanuma (H)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Mototsugu Oya (M)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Masahiro Jinzaki (M)

Department of Diagnostic Radiology, Keio University School of Medicine, Tokyo, Japan.

Classifications MeSH